Chromosome 9 deletions are more frequent than <i>FGFR3</i> mutations in flat urothelial hyperplasias of the bladder
Johanna M.M. van Oers(Erasmus MC), Arndt Hartmann(Friedrich-Alexander-Universität Erlangen-Nürnberg), Robert Stoehr(Friedrich-Alexander-Universität Erlangen-Nürnberg), Dirk Zaak, Ellen C. Zwarthoff(Erasmus MC), Theodorus van der Kwast(Erasmus MC), Christian G. Stief(LMU Klinikum), Simone Bertz(Taipei Institute of Pathology), Stefan Denzinger(University of Regensburg), Ferdinand Hofstaedter(University of Regensburg), C. Adam(Ludwig-Maximilians-Universität München), Ruth Knuechel(RWTH Aachen University)
Cited by 90
Related Papers
External irradiation with or without long-term androgen suppression for prostate cancer with high metastatic risk: 10-year results of an EORTC randomised study
|The Lancet Oncology|2010|944
Impact of Molecular Subtypes in Muscle-invasive Bladder Cancer on Predicting Response and Survival after Neoadjuvant Chemotherapy
|European Urology|2017|793
Comprehensive Transcriptional Analysis of Early-Stage Urothelial Carcinoma
|Cancer Cell|2016|654
Single-cell analysis reveals transcriptomic remodellings in distinct cell types that contribute to human prostate cancer progression
|Nature Cell Biology|2021|537
Efficient rescue of integrated shuttle vectors from transgenic mice: a model for studying mutations in vivo.
|Proceedings of the National Academy of Sciences|1989|493